BNP Paribas Financial Markets
DFTX

BNP Paribas Financial Markets’s Definium Therapeutics DFTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.54M Buy
96,510
+73,154
+313% +$1.81M ﹤0.01% 2177
2026
Q1 		$441K Buy
23,356
+973
+4% +$16.5K ﹤0.01% 3655
2025
Q4 		$300K Buy
22,383
+7,063
+46% +$87.4K ﹤0.01% 3861
2025
Q3 		$181K Buy
15,320
+6,903
+82% +$64.4K ﹤0.01% 4053
2025
Q2 		$54.6K Buy
8,417
+3,020
+56% +$19.9K ﹤0.01% 4229
2025
Q1 		$31.6K Sell
5,397
-5,234
-49% -$37.5K ﹤0.01% 4424
2024
Q4 		$74K Buy
+10,631
New +$73.1K ﹤0.01% 4280

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BNP Paribas Financial Markets's DFTX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Definium Therapeutics (DFTX) stake by 313% in Q2 2026, buying an estimated $1.81M and bringing the position to 96,510 shares worth $4.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

BNP Paribas Financial Markets first reported a position in DFTX in Q4 2024 and has held it in 7 quarters since. 340 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • BNP Paribas Financial Markets held 96,510 shares of Definium Therapeutics worth $4.54M as of Q2 2026.
  • BNP Paribas Financial Markets bought 73,154 Definium Therapeutics shares in Q2 2026, an estimated $1.81M.
  • Definium Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2177 holding.
  • BNP Paribas Financial Markets first reported a position in Definium Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 340 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.